STOCK TITAN

[Form 4] Kindly MD, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Tyler Matthew Evans, identified as Chief Investment Officer and a director of Kindly MD, Inc. (NAKA), reported on Form 4 that on 08/14/2025 he acquired 2,232,114 shares of the issuer’s common stock at a reported price of $0, increasing his total beneficial ownership to 2,410,685 shares. The filing is signed on 08/22/2025. The form shows a non-derivative acquisition only and provides no additional explanatory detail about the mechanics or consideration for the transaction.

Tyler Matthew Evans, indicato come Chief Investment Officer e amministratore di Kindly MD, Inc. (NAKA), ha dichiarato nel Form 4 che il 14/08/2025 ha acquisito 2.232.114 azioni ordinarie dell’emittente a un prezzo riportato di $0, portando la sua partecipazione beneficiaria totale a 2.410.685 azioni. La comunicazione è firmata in data 22/08/2025. Il modulo indica esclusivamente un’acquisizione non derivata e non fornisce ulteriori dettagli sulle modalità o sulla controprestazione dell’operazione.

Tyler Matthew Evans, identificado como Chief Investment Officer y director de Kindly MD, Inc. (NAKA), informó en el Form 4 que el 14/08/2025 adquirió 2.232.114 acciones comunes del emisor a un precio declarado de $0, aumentando su propiedad beneficiaria total a 2.410.685 acciones. La presentación está firmada el 22/08/2025. El formulario solo muestra una adquisición no derivada y no aporta detalles adicionales sobre la mecánica o la contraprestación de la transacción.

Tyler Matthew Evans는 Kindly MD, Inc.(NAKA)의 Chief Investment Officer 겸 이사로 확인되며, Form 4에 따르면 2025-08-14에 발행회사의 보통주 2,232,114주를 보고된 가격 $0로 취득하여 총 실질 보유주식 수를 2,410,685주로 늘렸습니다. 해당 서류는 2025-08-22에 서명되었습니다. 양식에는 비파생(non-derivative) 취득만 기재되어 있으며 거래의 방식이나 대가에 관한 추가 설명은 없습니다.

Tyler Matthew Evans, identifié comme Chief Investment Officer et administrateur de Kindly MD, Inc. (NAKA), a déclaré sur le Form 4 que le 14/08/2025 il a acquis 2 232 114 actions ordinaires de l’émetteur à un prix déclaré de 0 $, portant sa détention bénéficiaire totale à 2 410 685 actions. Le document est signé le 22/08/2025. Le formulaire n’indique qu’une acquisition non dérivée et ne fournit aucun détail supplémentaire sur les modalités ou la contrepartie de la transaction.

Tyler Matthew Evans, angegeben als Chief Investment Officer und Direktor von Kindly MD, Inc. (NAKA), meldete im Formular 4, dass er am 14.08.2025 2.232.114 Stammaktien des Emittenten zu einem angegebenen Preis von $0 erworben hat, wodurch sein gesamtes wirtschaftliches Eigentum auf 2.410.685 Aktien anstieg. Die Einreichung ist datiert und unterschrieben am 22.08.2025. Das Formular verzeichnet nur einen nicht-derivativen Erwerb und enthält keine weiteren erläuternden Angaben zu den Modalitäten oder der Gegenleistung der Transaktion.

Positive
  • Insider acquisition disclosed: Reporting person acquired 2,232,114 common shares, increasing transparency about insider ownership.
Negative
  • None.

Insights

TL;DR: Insider acquired a large block of company stock; filing reports quantity but not economic consideration.

The Form 4 discloses a non-derivative acquisition of 2,232,114 common shares by Tyler Evans, bringing his total to 2,410,685 shares. The transaction date is 08/14/2025 and the report shows a price of $0, with no derivative activity disclosed. From a securities-transaction perspective, the report documents a material shareholding change by a senior officer and director. However, the filing lacks contextual details on how the acquisition was executed or funded, which limits assessment of economic impact.

TL;DR: Officer/director reported sizable share acquisition; the $0 price notation needs clarification in follow-up filings.

As Chief Investment Officer and director, Evans’ increased stake to 2,410,685 shares is notable for ownership disclosure and governance transparency. The Form 4 contains the required signature and dates but does not explain the $0 price or indicate a Rule 10b5-1 plan; absence of that detail means investors must rely solely on the disclosed numbers. This filing satisfies the basic Section 16 reporting obligation but invites questions about the transaction’s nature that are not answered in this record.

Tyler Matthew Evans, indicato come Chief Investment Officer e amministratore di Kindly MD, Inc. (NAKA), ha dichiarato nel Form 4 che il 14/08/2025 ha acquisito 2.232.114 azioni ordinarie dell’emittente a un prezzo riportato di $0, portando la sua partecipazione beneficiaria totale a 2.410.685 azioni. La comunicazione è firmata in data 22/08/2025. Il modulo indica esclusivamente un’acquisizione non derivata e non fornisce ulteriori dettagli sulle modalità o sulla controprestazione dell’operazione.

Tyler Matthew Evans, identificado como Chief Investment Officer y director de Kindly MD, Inc. (NAKA), informó en el Form 4 que el 14/08/2025 adquirió 2.232.114 acciones comunes del emisor a un precio declarado de $0, aumentando su propiedad beneficiaria total a 2.410.685 acciones. La presentación está firmada el 22/08/2025. El formulario solo muestra una adquisición no derivada y no aporta detalles adicionales sobre la mecánica o la contraprestación de la transacción.

Tyler Matthew Evans는 Kindly MD, Inc.(NAKA)의 Chief Investment Officer 겸 이사로 확인되며, Form 4에 따르면 2025-08-14에 발행회사의 보통주 2,232,114주를 보고된 가격 $0로 취득하여 총 실질 보유주식 수를 2,410,685주로 늘렸습니다. 해당 서류는 2025-08-22에 서명되었습니다. 양식에는 비파생(non-derivative) 취득만 기재되어 있으며 거래의 방식이나 대가에 관한 추가 설명은 없습니다.

Tyler Matthew Evans, identifié comme Chief Investment Officer et administrateur de Kindly MD, Inc. (NAKA), a déclaré sur le Form 4 que le 14/08/2025 il a acquis 2 232 114 actions ordinaires de l’émetteur à un prix déclaré de 0 $, portant sa détention bénéficiaire totale à 2 410 685 actions. Le document est signé le 22/08/2025. Le formulaire n’indique qu’une acquisition non dérivée et ne fournit aucun détail supplémentaire sur les modalités ou la contrepartie de la transaction.

Tyler Matthew Evans, angegeben als Chief Investment Officer und Direktor von Kindly MD, Inc. (NAKA), meldete im Formular 4, dass er am 14.08.2025 2.232.114 Stammaktien des Emittenten zu einem angegebenen Preis von $0 erworben hat, wodurch sein gesamtes wirtschaftliches Eigentum auf 2.410.685 Aktien anstieg. Die Einreichung ist datiert und unterschrieben am 22.08.2025. Das Formular verzeichnet nur einen nicht-derivativen Erwerb und enthält keine weiteren erläuternden Angaben zu den Modalitäten oder der Gegenleistung der Transaktion.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Evans Tyler Matthew

(Last) (First) (Middle)
5097 SOUTH 900 EAST, SUITE 100

(Street)
SALT LAKE CITY UT 84117

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Kindly MD, Inc. [ NAKA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Investment Officer
3. Date of Earliest Transaction (Month/Day/Year)
08/14/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/14/2025 A 2,232,114 A $0 2,410,685 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
/s/ Tyler Evans 08/22/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Tyler Matthew Evans report on the Form 4 for NAKA?

He reported a non-derivative acquisition of 2,232,114 common shares on 08/14/2025, bringing his ownership to 2,410,685 shares.

What price was reported for the shares acquired in the Form 4 (NAKA)?

The filing shows a reported price of $0 for the acquisition; no further explanation is provided in the document.

What is Tyler Evans’ role at Kindly MD, Inc. as shown on the Form 4?

The Form 4 lists Tyler Matthew Evans as a Director and Chief Investment Officer of Kindly MD, Inc.

When was the Form 4 signed and filed by the reporting person?

The signature block shows the form was signed by /s/ Tyler Evans on 08/22/2025.

Does the Form 4 report any derivative securities transactions for NAKA?

No. Table II for derivative securities contains no reported transactions; only a non-derivative acquisition is recorded.
Kindly Md, Inc.

NASDAQ:NAKA

NAKA Rankings

NAKA Latest News

NAKA Latest SEC Filings

NAKA Stock Data

76.75M
356.04M
5.09%
0.25%
7.81%
Medical Care Facilities
Services-health Services
Link
United States
SALT LAKE CITY